Xlife Sciences AG
SIX:XLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AGS Corp
TSE:3648
|
JP |
Xlife Sciences AG
Total Current Assets
Xlife Sciences AG
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Xlife Sciences AG
SIX:XLS
|
Total Current Assets
CHf14.2m
|
CAGR 3-Years
79%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Bachem Holding AG
SIX:BANB
|
Total Current Assets
CHf726.8m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
13%
|
|
|
Siegfried Holding AG
SIX:SFZN
|
Total Current Assets
CHf1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Lonza Group AG
SIX:LONN
|
Total Current Assets
CHf4.6B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
10%
|
|
|
Tecan Group AG
SIX:TECN
|
Total Current Assets
CHf711.7m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
PolyPeptide Group AG
SIX:PPGN
|
Total Current Assets
€324.9m
|
CAGR 3-Years
9%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Xlife Sciences AG
Glance View
Xlife Sciences AG focuses on the value development of performance promising technologies in life sciences. The company is headquartered in Zurich, Zuerich and currently employs 19 full-time employees. The company went IPO on 2019-09-30. The firm focuses on investing in technologies in the life science industry. The company supports researchers and entrepreneurs in positioning, structuring, developing and implementing their concepts. The firm offers its investors direct access to the further development of technologies at a very early stage. The firm cooperates with industrial partners and universities.
See Also
What is Xlife Sciences AG's Total Current Assets?
Total Current Assets
14.2m
CHF
Based on the financial report for Dec 31, 2024, Xlife Sciences AG's Total Current Assets amounts to 14.2m CHF.
What is Xlife Sciences AG's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
23%
Over the last year, the Total Current Assets growth was -22%. The average annual Total Current Assets growth rates for Xlife Sciences AG have been 79% over the past three years , 23% over the past five years .
